Connection

Janardan Pandey to Infusions, Subcutaneous

Back to Details
This is a "connection" page, showing publications Janardan Pandey has written about Infusions, Subcutaneous.
Janardan Pandey
Connection Strength
0.037
Infusions, Subcutaneous
  1. Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults. PLoS Med. 2018 01; 15(1):e1002493.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.